Socio Today
Congenital Heart Disease (CHD), known locally in Indonesia as Penyakit Jantung Bawaan (PJB), remains one of the most significant challenges to neonatal health in the Southeast Asian archipelago, contributing to a substantial portion of infant mortality rates. While the precise etiology of these structural heart defects often remains elusive to medical science, healthcare experts are increasingly emphasizing the identification of modifiable risk factors and the implementation of early screening protocols to mitigate the impact of the condition. According to dr. Rizky Adriansyah, M.Ked, a pediatric specialist and Chairman of the Cardiology Coordination Staff Unit of the Indonesian Pediatric Society (IDAI), the focus must shift toward preventive measures during pregnancy and rapid diagnostic intervention immediately following birth.
The urgency of this health crisis was highlighted during a comprehensive webinar hosted on February 14, 2023, where medical experts gathered to discuss the current landscape of pediatric cardiology in Indonesia. Data presented during the session underscored a sobering reality: CHD is the second largest contributor to neonatal death in Indonesia, accounting for approximately 17 percent of fatalities in the first month of life, trailing only prematurity. Despite the prevalence of the condition, a significant gap remains between the number of cases and the capacity of the national healthcare system to address them.
The Landscape of Congenital Heart Disease in Indonesia
The statistical burden of CHD in Indonesia aligns with global trends reported by the World Health Organization (WHO), which suggests that approximately one in every 100 newborns is affected by some form of heart defect. On a global scale, this translates to millions of children, but in the specific context of Indonesia—a nation with a high birth rate—the raw numbers are particularly daunting. Experts estimate that between 40,000 and 50,000 babies are born with CHD annually in Indonesia. Of these, approximately 25 percent, or 10,000 to 12,500 infants, suffer from "critical" CHD, a condition that requires surgical intervention or catheterization within the first year, and often within the first days or weeks of life, to ensure survival.
Dr. Rizky noted that currently, less than 50 percent of these cases are successfully managed or treated within the country. This treatment gap is the result of a complex interplay of factors, including geographical barriers in the sprawling archipelago, a shortage of specialized pediatric cardiologists and thoracic surgeons, limited diagnostic infrastructure in rural provinces, and a general lack of public awareness regarding the symptoms of heart distress in infants.
Identifying and Mitigating Prenatal Risk Factors
While the specific cause of a heart defect in any individual child is often impossible to pinpoint, medical literature has identified a cluster of risk factors that significantly increase the statistical probability of a child being born with CHD. Dr. Rizky identified three primary factors that have gained prominence in recent clinical discussions: maternal infections, nutritional deficiencies, and the consumption of specific medications during the first trimester of pregnancy.
1. The Rubella Threat and the Importance of Vaccination
One of the most potent risk factors for CHD is maternal infection with the Rubella virus during early pregnancy. Rubella, often referred to as "German Measles," can lead to Congenital Rubella Syndrome (CRS) if the mother is infected during the first trimester, a critical period when the fetal heart is forming. CRS can cause a variety of defects, most notably Patent Ductus Arteriosus (PDA) and pulmonary artery stenosis.
To combat this, the Indonesian Ministry of Health has been aggressive in its promotion of the MR (Measles-Rubella) vaccine. Ensuring that women of childbearing age are immunized before pregnancy is considered the most effective way to eliminate this specific risk factor. Dr. Rizky emphasized that once a child is born with a defect resulting from a maternal infection, the opportunity for primary prevention has passed, making pre-conception and early-pregnancy vigilance paramount.
2. Folic Acid Deficiency
The role of nutrition in fetal development cannot be overstated. Folic acid (Vitamin B9) is essential for DNA synthesis and the proper formation of the neural tube and the cardiovascular system. A deficiency in this nutrient during the earliest stages of gestation—often before a woman even realizes she is pregnant—is strongly linked to an increased risk of heart defects. Public health initiatives in Indonesia have sought to address this through the distribution of prenatal supplements and the fortification of staple foods, yet many women in remote areas still lack access to adequate nutritional support.
3. Medication and Chemical Exposure
The third major risk factor involves the maternal consumption of certain medications, particularly anti-seizure drugs (anticonvulsants) and certain types of acne medication (retinoids), which have been shown to interfere with fetal cardiac development. Furthermore, while previous medical consensus focused heavily on maternal smoking and alcohol consumption as primary drivers of CHD, dr. Rizky pointed out that the data is nuanced. Many mothers who do not smoke or consume alcohol still give birth to children with CHD, suggesting that while lifestyle choices are important, they are only part of a much larger environmental and genetic puzzle.
The Critical Window: Early Detection and Diagnosis
In the absence of a known cure for the underlying causes of CHD, the medical community’s best defense is early detection. The "critical" window for diagnosing CHD is often within the first 24 to 48 hours after birth. If a defect is missed during this period, the infant’s health can deteriorate rapidly as the circulatory system transitions from fetal to neonatal physiology.
Pulse Oximetry Screening
One of the most significant advancements in neonatal care is the implementation of pulse oximetry screening. This non-invasive, inexpensive, and rapid test measures the oxygen saturation in a newborn’s blood. Dr. Rizky explained that by placing sensors on the baby’s right hand and either foot, healthcare providers can detect differences in oxygen levels that might indicate a heart defect. This procedure takes less than five minutes and is sensitive enough to catch many cases of critical CHD that might not be apparent through physical examination alone.
Clinical Symptoms and the Role of Primary Care
For infants who are not diagnosed in the immediate postpartum period, parents and primary healthcare providers must remain vigilant for clinical signs. These include:
- Poor Weight Gain: Infants with heart defects often burn more calories just trying to breathe and circulate blood, leading to "failure to thrive."
- Cyanosis: A bluish tint to the skin, lips, or fingernails, indicating low oxygen levels.
- Tachypnea: Rapid or labored breathing, especially during feeding.
- Heart Murmurs: Unusual sounds heard through a stethoscope during a routine check-up.
Dr. Rizky noted that if a healthcare provider, such as a midwife or general practitioner, hears a heart murmur or notices abnormal oxygen levels, the child should be referred immediately for an echocardiography—an ultrasound of the heart that provides a definitive diagnosis of its structure and function.
Systemic Challenges and the Path Forward
The disparity in CHD outcomes in Indonesia is largely a reflection of the country’s healthcare infrastructure. Most specialized pediatric cardiac centers are concentrated on the island of Java, particularly in Jakarta at the National Cardiovascular Center Harapan Kita. For a family in East Nusa Tenggara or Papua, accessing such care is a monumental task involving significant travel costs and logistical hurdles.
Furthermore, there is a dire need for more human resources. The number of pediatric cardiologists in Indonesia is currently insufficient to meet the needs of a population of over 270 million people. Expanding training programs and incentivizing specialists to practice in underserved regions are essential components of a long-term solution.
To bridge the information gap, dr. Rizky and the IDAI have turned to digital platforms. The YouTube channel "Sehatkan Jantung Anak Indonesia" (Healthy Indonesian Children’s Hearts) serves as an educational hub, providing both parents and healthcare workers with tutorials on how to perform screenings and recognize early warning signs. This democratization of medical knowledge is crucial in a country where the ratio of doctors to patients remains low.
Analysis of Socio-Economic Implications
The impact of untreated or late-diagnosed CHD extends beyond individual health; it has profound socio-economic consequences. Children with uncorrected heart defects often face a lifetime of chronic illness, limiting their educational opportunities and future productivity. For families, the cost of long-term care and repeated hospitalizations can be catastrophic, pushing vulnerable households into poverty.
From a policy perspective, investing in early CHD screening and maternal health is a cost-effective strategy. The cost of a pulse oximeter is negligible compared to the cost of emergency intensive care for a baby in cardiac collapse. By integrating CHD screening into the standard newborn care package across all Indonesian provinces, the government can significantly reduce the neonatal mortality rate and improve the quality of life for thousands of citizens.
Conclusion: A Call for Integrated Action
The fight against Congenital Heart Disease in Indonesia requires a multi-pronged approach involving government intervention, clinical excellence, and public empowerment. While the medical community continues to research the unknown causes of these defects, the path forward is clear: emphasize maternal vaccination and nutrition, standardize newborn screening with pulse oximetry, and expand the reach of specialized cardiac care.
As dr. Rizky Adriansyah concluded in his address, the prevention of CHD complications must begin in the womb and continue through the first hours of life. By the time a baby is born, the window for structural prevention has closed, but the window for life-saving intervention is just opening. Through increased awareness and a more robust healthcare infrastructure, Indonesia can hope to turn the tide against this silent killer of its youngest citizens.
